{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2018:HOGGEUTBP4GQR7YVPKAHVAX6WW","short_pith_number":"pith:HOGGEUTB","schema_version":"1.0","canonical_sha256":"3b8c6252617f0d08ff157a807a82feb59b9f6b6bafe806f402a3155ce2e87168","source":{"kind":"arxiv","id":"1803.10130","version":1},"attestation_state":"computed","paper":{"title":"Blinded and unblinded sample size re-estimation in crossover trials balanced for period","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Adrian Mander, James Wason, Michael Grayling","submitted_at":"2018-03-27T15:22:13Z","abstract_excerpt":"The determination of the sample size required by a crossover trial typically depends on the specification of one or more variance components. Uncertainty about the value of these parameters at the design stage means that there is often a risk a trial may be under- or over-powered. For many study designs, this problem has been addressed by considering adaptive design methodology that allows for the re-estimation of the required sample size during a trial. Here, we propose and compare several approaches for this in multi-treatment crossover trials. Specifically, regulators favour re-estimation p"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1803.10130","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2018-03-27T15:22:13Z","cross_cats_sorted":[],"title_canon_sha256":"8333ad6addb662071d174a76cbfc9bb17d02e8c079706f2d4b43a7bbaa74d85e","abstract_canon_sha256":"c92d79ddfdae5c27f265d643e6efbf3e7e45466051a66a37ced67a81085c6a3b"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:20:00.343783Z","signature_b64":"lEsr+PP8uszz1aROmI4u+uP9mf2EmJAsVzWcxtXCDEsh9ssQBT+tcdm6GtQR/mTD/ExpZAGMJL9nLIUfH0G8CA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"3b8c6252617f0d08ff157a807a82feb59b9f6b6bafe806f402a3155ce2e87168","last_reissued_at":"2026-05-18T00:20:00.343050Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:20:00.343050Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Blinded and unblinded sample size re-estimation in crossover trials balanced for period","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Adrian Mander, James Wason, Michael Grayling","submitted_at":"2018-03-27T15:22:13Z","abstract_excerpt":"The determination of the sample size required by a crossover trial typically depends on the specification of one or more variance components. Uncertainty about the value of these parameters at the design stage means that there is often a risk a trial may be under- or over-powered. For many study designs, this problem has been addressed by considering adaptive design methodology that allows for the re-estimation of the required sample size during a trial. Here, we propose and compare several approaches for this in multi-treatment crossover trials. Specifically, regulators favour re-estimation p"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1803.10130","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1803.10130","created_at":"2026-05-18T00:20:00.343167+00:00"},{"alias_kind":"arxiv_version","alias_value":"1803.10130v1","created_at":"2026-05-18T00:20:00.343167+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1803.10130","created_at":"2026-05-18T00:20:00.343167+00:00"},{"alias_kind":"pith_short_12","alias_value":"HOGGEUTBP4GQ","created_at":"2026-05-18T12:32:28.185984+00:00"},{"alias_kind":"pith_short_16","alias_value":"HOGGEUTBP4GQR7YV","created_at":"2026-05-18T12:32:28.185984+00:00"},{"alias_kind":"pith_short_8","alias_value":"HOGGEUTB","created_at":"2026-05-18T12:32:28.185984+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW","json":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW.json","graph_json":"https://pith.science/api/pith-number/HOGGEUTBP4GQR7YVPKAHVAX6WW/graph.json","events_json":"https://pith.science/api/pith-number/HOGGEUTBP4GQR7YVPKAHVAX6WW/events.json","paper":"https://pith.science/paper/HOGGEUTB"},"agent_actions":{"view_html":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW","download_json":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW.json","view_paper":"https://pith.science/paper/HOGGEUTB","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1803.10130&json=true","fetch_graph":"https://pith.science/api/pith-number/HOGGEUTBP4GQR7YVPKAHVAX6WW/graph.json","fetch_events":"https://pith.science/api/pith-number/HOGGEUTBP4GQR7YVPKAHVAX6WW/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW/action/timestamp_anchor","attest_storage":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW/action/storage_attestation","attest_author":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW/action/author_attestation","sign_citation":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW/action/citation_signature","submit_replication":"https://pith.science/pith/HOGGEUTBP4GQR7YVPKAHVAX6WW/action/replication_record"}},"created_at":"2026-05-18T00:20:00.343167+00:00","updated_at":"2026-05-18T00:20:00.343167+00:00"}